c-Myc is an important mediator of apoptosis in cytokine- or serum-depr
ived cells and sensitizes various cell types to tumor necrosis factor
alpha (TNF) cytotoxicity, However, downstream mediators of c-Myc-depen
dent apoptosis are largely unknown. In this study, we investigated whe
ther one or more cyclins which, like c-Myc, are important regulators o
f the cell cycle are involved in TNF-induced apoptosis downstream of c
-Myc, Cyclin D3 and c-Myc levels in HeLa and fibrosarcoma cells correl
ated with sensitivity of these cells to TNF-induced apoptosis, as both
proteins were highly expressed in TNF-sensitive HeLa D98 cells and HT
-1080 fibrosarcoma cells but not in their TNF-resistant counterparts,
HeLa H21 and SS-HT-1080 cells, respectively, All other cyclins tested
were equally expressed in all tumor cell lines. Reduction in the expre
ssion of c-Myc by dexamethasone or inhibition of the transcriptional a
ctivity of c-Myc by introduction of a dominant negative form of c-Myc
into TNF-sensitive HeLa D98 cells strongly suppressed the expression o
f cyclin D3 (but none of the other cyclins) and rendered the cells res
istant to TNF-induced apoptosis, Conversely, introduction of the c-myc
gene into TNF-resistant, c-Myc- and cyclin DJ-deficient HeLa H21 cell
s resulted in enhanced cyclin D3 expression and TNF killing, When cycl
in D3 expression in HeLa cells was altered by sense or antisense cycli
n D3 cDNA, there was a concomitant alteration in their susceptibility
to TNF-induced apoptosis without any change in c-Myc levels, Overall,
our results show that cyclin D3 sensitizes tumor cells to TNF-induced
apoptosis and indicate that the expression of c-Myc and expression of
cyclin D3 in HeLa and in HT-1080 fibrosarcoma cells are closely linked
.